HER2-Positive Breast Cancer Treatment Market Insights and Forecast to 2032
24 janv. 2024 10h35 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. ...
United States IBRANCE (Palbociclib) Drug Insight and Market Forecasts Report 2023-2032
14 févr. 2023 08h03 HE
|
Research and Markets
Dublin, Feb. 14, 2023 (GLOBE NEWSWIRE) -- The "IBRANCE Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering."IBRANCE Drug Insight and Market...
ActivX Biosciences reports key findings that could impact the use of clinically approved CDK4/6 inhibitors in the treatment of cancer patients
11 mars 2019 10h00 HE
|
ActivX Biosciences
LA JOLLA, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- ActivX Biosciences, Inc., a wholly-owned subsidiary of Kyorin Pharmaceutical Co., Ltd. (Tokyo), announces a report published in a high profile,...